share_log

ADC Therapeutics Expects That Product Revenues, Net, Will Be About $19.8M For Three Months Ended Dec. 31, 2022; Expects Cash And Cash Equivalents Will Be About $326.4M As Of Dec. 31, 2022

Benzinga Real-time News ·  Feb 2, 2023 06:34
ADC Therapeutics Expects That Product Revenues, Net, Will Be About $19.8M For Three Months Ended Dec. 31, 2022; Expects Cash And Cash Equivalents Will Be About $326.4M As Of Dec. 31, 2022
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment